SCHEMBL4350176

SCHEMBL4350176

COc1cccc(CNC(=O)C=Cc2c[nH]c3ncccc23)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 1/20 0.56
▸ FGFR4 P22455 1/20 0.56
▸ THRB P10828 2/20 0.51
▸ GSK3B P49841 3/20 0.50
▸ HPGD P15428 2/20 0.49
▸ GABRP O00591 1/20 0.49
▸ GABRD O14764 1/20 0.49
▸ GABRA1 P14867 1/20 0.49
▸ GABRB1 P18505 1/20 0.49
▸ GABRG2 P18507 1/20 0.49
▸ GABRB3 P28472 1/20 0.49
▸ GABRA5 P31644 1/20 0.49
▸ GABRA3 P34903 1/20 0.49
▸ GABRA2 P47869 1/20 0.49
▸ GABRB2 P47870 1/20 0.49
▸ GABRA4 P48169 1/20 0.49
▸ GABRE P78334 1/20 0.49
▸ GABRA6 Q16445 1/20 0.49
▸ GABRG1 Q8N1C3 1/20 0.49
▸ GABRG3 Q99928 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350169 1.00 FGFR1 (0.56) FGFR1FGFR4THRBGSK3BHPGD
SCHEMBL4353161 0.85 CDC7 (0.51) GSK3BKMT2AROCK2HDAC1
SCHEMBL4344099 0.85 NPSR1 (0.51) GSK3BGABRPGABRDGABRA1GABRB1
SCHEMBL4353164 0.85 CDC7 (0.51) GSK3BKMT2AROCK2HDAC1
SCHEMBL4344092 0.85 NPSR1 (0.51) GSK3BGABRPGABRDGABRA1GABRB1
SCHEMBL4346212 0.84 GSK3B (0.58) GSK3BKMT2AALDH1A1LMNAHDAC1
SCHEMBL4346216 0.84 GSK3B (0.58) GSK3BKMT2AALDH1A1LMNAHDAC1
SCHEMBL4667740 0.82 HPGD (0.52) FGFR1FGFR4THRBHPGDKMT2A
SCHEMBL4667735 0.82 HPGD (0.52) FGFR1FGFR4THRBHPGDKMT2A
SCHEMBL24765334 0.82 FGFR1 (0.52) FGFR1FGFR4HPGDGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP claimed
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP disclosed
Send feedback